Daniel Schulman, DPM
Foot Surgery · Yuma, AZNPI 1144317314
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (56.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Wishbone Medical Inc. accounts for 88.6% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2020 at $16,184 and has fallen 99.3% since, to $108 in 2025.
Across 145 payments — averaging $194.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Wishbone Medical Inc.$25K
- Medtronic$1K
- Musculoskeletal Transplant Foundation Inc.$466
- Abbott$392
- Ortho Solutions Inc$261
- Philips North America LLC$162
- plus $866 from 16 others
What the payments were for
- Royalty or licence$15,92056%
- Consulting fees$8,25029%
- Food & beverage$4,09514%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Wishbone Medical Inc. | 17 | $25,046 |
| Medtronic(2 entities) | 66 | $1,071 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $466 |
| Abbott | 13 | $392 |
| Ortho Solutions Inc | 3 | $261 |
| Philips North America LLC | 7 | $162 |
| Zimmer Biomet | 2 | $135 |
| Globus Medical | 2 | $96 |
| Angiodynamics, Inc. | 3 | $84 |
| Tactile Systems Technology Inc | 5 | $78 |
| Trice Medical, Inc. | 4 | $74 |
| Stryker | 2 | $71 |
| Smith+Nephew | 4 | $57 |
| DJO, LLC | 2 | $55 |
| Organogenesis Inc. | 2 | $43 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $40 |
| Orthofix Medical, Inc. | 5 | $32 |
| Cardiovascular Systems Inc. | 1 | $31 |
| Osiris Therapeutics Inc. | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| Bioventus LLC | 1 | $15 |
| Melinta Therapeutics, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AlloMate$13,217
- AlloMate B562KITABSI200 - 400$11,644
- WishBone MG$3,912
- SilverHawk$129
How this compares
Too few foot surgery providers in Arizonato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 31 | $4,827 |
| Mupirocin | 18 | $362 |
| Doxycycline Hyclate | 15 | $357 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Yuma
- Tharesh UdupaSun City$96K
- Timothy ShortTucson$3K
- Barry KaplanPhoenix$788
- Leobardo CarranzaGlendale$778
- Nitin NandaGlendale$599
- Kenneth BlocherTucson$285
- David JenkinsGlendale$84
- Jeffrey PageGlendale$22
- Adam LuSacaton$12
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.